BRCA2 p.Arg2659Thr
c.7976G>C · rs80359027 · VCV52455
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9904 | likely pathogenic ✓ concordant with ClinVar · top 1% in BRCA2 |
|---|---|---|
| REVEL | 0.837 | moderately pathogenic-leaning |
| ⇒ AlphaMissense and REVEL both call this damaging. | ||
| Splicing | ||
| SpliceAI | Δ0.88 | donor loss at this position · raw score · deltas |
| Pangolin | Δ0.77 | loss · gain 0.01 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 1.03 | unconstrained · MANE · 47 kb · p 0.059 · regional, not allelic |
| Overall | ||
| CADD | 31.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- BRCA2
- Protein
- p.Arg2659Thr
- Coding
- c.7976G>C
- MANE Select
- NM_000059
- dbSNP
- rs80359027
- Type
- single nucleotide variant
- Location
- chr13:32362693 (GRCh38)
- Gene constraint
- LOEUF 0.803 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Residue 2659
- a UniProt-annotated variant site (in bc; uncertain significance); the 'interaction with sem1' region
Disease context
breast-ovarian cancer, familial, susceptibility to, 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: hereditary neoplastic syndrome
For Hereditary breast and/or ovarian cancer syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult, Elderly
Similar variants
- BRCA2 p.Arg2659Gly Pathogenic ★★★ same residue
- BRCA2 p.Arg2659Lys Pathogenic ★★ same residue
- BRCA2 p.Arg2659Ser Likely pathogenic ★ same residue
- BRCA2 p.Arg2659Ile Uncertain significance ★★ ⚠ same residue
- BRCA2 p.Arg2659= Uncertain significance ★ same residue
- BRCA2 c.316+1G>T Pathogenic ★★★ same condition
- BRCA2 c.316+2T>C Pathogenic ★★★ same condition
- BRCA2 c.316+5G>A Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca2-p-arg2659thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown